10000
187
8
3
2
| Cat. No. | Product Name | ||
|---|---|---|---|
| CL0092 | GSK-3 inhibitor kit | ||
| DP9100 | CB1-2化合物库 | ||
| L8500 | HIF-1化合物库 | 1352 compounds | |
| A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies； | |||
| DC1160 | 特权片段注释化合物库-Toll-like and Il-1 receptors | ||
| L7800 | 高溶解性片段库 | 2731 compounds | |
| Structurally diverse, medicinally active, and unique chemistry (strong IP potential); | |||
| CL0145 | Casein Kinase inhibitor kit | ||
| L3800 | NF-κB 通路分子库 | 560 compounds | |
| A unique collection of 560 compounds targeting NF-κB signaling for high throughput screening and high content screening; | |||
| L2191 | 抗乳腺癌化合物库 | 1965 compounds | |
| A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study； | |||
| L1100 | 蛋白酶抑制剂库 | 344 compounds | |
| A unique collection of 344 protease and proteasome inhibitors for research in chemical genomics, and drug screening; | |||
| DO2200 | 共价抑制剂库CD | ||
| L7600 | 趋化因子抑制剂库 | 59 compounds | |
| A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening; | |||
| L5900 | 血脑屏障通透化合物库 | 516 compounds | |
| A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| CL0149 | β-/γ-secretase inhibitor kit | ||
| DO1200 | 药物靶点库 | ||
| L5610 | Golden骨架库 | 10000 compounds | |
| Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source； | |||
| L1710 | 抗COVID-19化合物库 | 1160 compounds | |
| A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents； | |||
| CL0117 | DPP4 inhibitor kit | ||
| L6010 | 天然产物库 | 3720 compounds | |
| A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
| L5600 | Mini骨架库 | 5033 compounds | |
| Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5033 compounds representing 5033 scaffolds； | |||
| L9410 | 共价抑制剂库 | 941 compounds | |
| A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc. | |||
| L8720 | 细胞焦亡化合物库 | 1077 compounds | |
| 1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | |||
| L4150 | 新颖已知活性精选库 | 990 compounds | |
| It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 990 compounds without compro | |||
| L6120 | 黄酮类天然产物库 | 477 compounds | |
| A unique collection of 477 flavonoids can be used for high throughput and high content screening； | |||
| CL0057 | PI3K inhibitor kit | ||
| CL0085 | HSP inhibitor kit | ||
| L8300 | 染色质修饰分子库 | 256 compounds | |
| A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | |||
| L6600 | 胃肠炎天然产物库 | 223 compounds | |
| A unique collection of 223 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS); | |||
| CL0094 | FLT3 inhibitor kit | ||
| L6700 | 抗癌天然产物库 | 1800 compounds | |
| A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L3980 | DNA损伤/修复库Plus | 667 compounds | |
| Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
| CL0144 | Endothelin Receptor antagonist kit | ||
| L5700 | 精选片段库 | 246 compounds | |
| A unique collection of 246 fragment-like small molecules for FBDD; | |||
| L8800 | 药物片段库 | 1158 compounds | |
| 1158 drug fragments，a must-have tool for FBDD; | |||
| L3700 | JAK-STAT 化合物库 | 256 compounds | |
| A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening; | |||
| L2180 | 抗肿瘤库Plus | 1468 compounds | |
| Well-chosen 1468 anti-tumor compounds with unique structures; | |||
| L1300 | PI3K/Akt/mTOR 化合物库 | 425 compounds | |
| A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | |||
| L9000 | 细胞凋亡化合物库 | 1796 compounds | |
| A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | |||
| L1610 | FDA 上市激酶抑制剂库 | 280 compounds | |
| Targetmol’s FDA-Approved Kinase Inhibitor Library contains 280 marketed drugs with proven kinase inhibitory activity. These kinases include Insulin/IGF Receptors、PI 3-Kinase、CaM Kinase II、JAK、PKA、CDK、JNK、PKC、CKI II、MAPK、RAF、EGFR、MEK、SAPK、GSK、MLCK、Src-family、IKK、PDGFR、VEGFR etc. FDA-Approved Kinase Inhibitor Library is a powerful tool for kinase drug development and related research. | |||
| L9700 | 内质网应激化合物库 | 193 compounds | |
| A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
| L2540 | 肠道微生物代谢化合物库 | 352 compounds | |
| A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS; | |||
| L2520 | 糖代谢化合物库 | 708 compounds | |
| 708 glycometabolism-related comounds, can be used for HTS and HCT; | |||
| L9500 | 表型筛选靶点鉴定库 | 1832 compounds | |
| A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening； | |||
| L9830 | 抗帕金森病化合物库 | 908 compounds | |
| A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
| L9840 | 抗阿尔茨海默症化合物库 | 1040 compounds | |
| A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
| L1600 | 激酶抑制剂库 | 2230 compounds | |
| A unique collection of 2230 kinase inhibitors for high throughput screening and high content screening for drug discovery in kinase related diseases; | |||
| L2620 | 神经退行性疾病化合物库 | 1622 compounds | |
| A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS； | |||
| L2400 | 内分泌激素分子库 | 813 compounds | |
| A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L2192 | 抗胰腺癌化合物库 | 2267 compounds | |
| A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS; | |||
| L6300 | 药食同源库 | 1088 compounds | |
| A unique collection of 1088 compounds from food as medicine for high throughput and high content screening; | |||
| L8700 | 铁死亡化合物库 | 800 compounds | |
| A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study； | |||
| L2800 | 5-羟色胺分子库 | 275 compounds | |
| A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
| L1120 | AMPK靶向分子库 | 64 compounds | |
| 64 well-chosen unique AMPK-targeted small molecules； | |||
| L2130 | 抗癌细胞代谢库 | 1280 compounds | |
| A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
| L2550 | 谷氨酰胺代谢化合物库 | 580 compounds | |
| A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer; | |||
| L9600 | 多肽分子库 | 533 compounds | |
| 533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
| L7100 | 抗肥胖化合物库 | 1359 compounds | |
| A unique collection of 1359 anti-obesity compounds for high throughput and high content screening; | |||
| L6400 | 海洋天然产物库 | 94 compounds | |
| A unique collection of 94 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
| L5500 | 毒性化合物库 | 277 compounds | |
| A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
| DC1170 | 特权片段注释化合物库-Oxidoreductases | ||
| CL0098 | HER2 inhibitor kit | ||
| CL0091 | MEK inhibitor kit | ||
| L3200 | 自噬库 | 1248 compounds | |
| A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L1000 | 上市药物库 | 2863 compounds | |
| A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L4900 | 心血管毒性化合物库 | 127 compounds | |
| A unique collection of 127 cardiotoxicity inducing compounds for toxicological study; | |||
| DC1150 | 特权片段注释化合物库-GPCR Family B | ||
| L2700 | 肾上腺素能受体化合物库 | 219 compounds | |
| A unique collection of 219 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification; | |||
| L2160 | 抗癌活性化合物库 | 2439 compounds | |
| A unique collection of 2439 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L7200 | 钙通道分子库 | 143 compounds | |
| A unique collection of 143 calcium channel blockers and agonists for high throughput and high content screening; | |||
| L2195 | 抗前列腺癌化合物库 | 2096 compounds | |
| 2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
| DC1100 | 特权片段注释化合物库-GPCR Frizzled family | ||
| CL0125 | AChE inhibitor kit | ||
| CL0055 | Potassium Channel inhibitor kit | ||
| L1200 | 表观遗传库 | 960 compounds | |
| Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L9411 | 半胱氨酸共价化合物库 | 72 compounds | |
| The cysteine covalent library contains 72 compounds. | |||
| L2110 | 抗癌上市药物库 | 1806 compounds | |
| A unique collection of 1806 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L2200 | 酪氨酸激酶分子库 | 746 compounds | |
| A unique collection of 746 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases; | |||
| L8710 | 铜死亡化合物库 | 411 compounds | |
| TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
| L6620 | 抗寄生虫天然产物库 | 233 compounds | |
| A unique collection of 233 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
| L7820 | 高溶解性微型片段化合物库 | 1082 compounds | |
| The compound library of highly soluble micro-fragments consists of 1082 low-molecular-weight fragments. | |||
| L4660 | 神经疾病库Plus | 1246 compounds | |
| Well-chosen 1246 compounds with unique structures targeting nervous system; | |||
| DP9200 | DGK抑制剂库 | ||
| L7000 | 活性脂质化合物库 | 385 compounds | |
| A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa | |||
| CL0127 | NOS inhibitor kit | ||
| L1310 | 细胞骨架化合物库 | 590 compounds | |
| A unique collection of 590 cytoskeleton-related compounds, can be used for HTS and HCS； | |||
| L6020 | 天然产物单体化合物库 | ||
| L8600 | 泛素化化合物库 | 214 compounds | |
| A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening； | |||
| LF1000 | 预制多样性库 | ||
| L7810 | 高溶解性多官能团片段化合物库 | 1159 compounds | |
| Highly soluble multifunctional fragment library contains 1159 kinds of fragment molecules. | |||
| CL0086 | Anti-dsDNA viruses compound kit | ||
| DC1030 | 特权片段注释化合物库-Epigenetics | ||
| CL0141 | Notch pathway inhibitor kit | ||
| L5300 | 线粒体靶向库 | 447 compounds | |
| A unique collection of 447 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | |||
| CL0116 | MAO inhibitor kit | ||
| CL0129 | Aurora Kinase inhibitor kit | ||
| L9230 | ReFRAME 相关化合物库 | 3274 compounds | |
| A unique collection of 3274 compounds for high-throughput screening and high-content screening, | |||
| L1380 | 转录因子库 | 704 compounds | |
| Well-chosen 704 compounds with unique structures targeting transcription factor; | |||
| L3900 | DNA 损伤和修复分子库 | 937 compounds | |
| A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| CL0128 | HMGCR inhibitor kit | ||
| CL0104 | NMDAR agonist/antagonist kit | ||
| L1110 | 微管靶向化合物库 | 80 compounds | |
| A unique collection of 80 microtubule-targeted compounds can be used in HTS and HCS; | |||
| L9850 | 口服活性化合物库 | 2484 compounds | |
| A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening. | |||
| DC1200 | 特权片段注释化合物库-Isomerases | ||
| DC1040 | 特权片段注释化合物库-Transferases | ||
| L5400 | 抗心血管疾病化合物库 | 1428 compounds | |
| A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| DC1140 | 特权片段注释化合物库-Ligand-gated | ||
| L2196 | 抗卵巢癌化合物库 | 1888 compounds | |
| L7900 | 成骨分子库 | 320 compounds | |
| A unique collection of 320 osteogenesis related compounds for high throughput and high content screening; | |||
| L6150 | 天然产物共价化合物库 | 596 compounds | |
| Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening. | |||
| DC1190 | 特权片段注释化合物库-Sigma Opioid receptors | ||
| L6720 | 抗COVID-19中药单体库 | 1162 compounds | |
| A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening； | |||
| CL0066 | P450 inhibitor kit | ||
| L9810 | 抗纤维化化合物库 | 1180 compounds | |
| A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | |||
| L6610 | 抗感染天然产物库 | 1070 compounds | |
| A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L2194 | 抗结直肠癌化合物库 | 1565 compounds | |
| 1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
| CL0079 | Adenosine Receptor inhibitor kit | ||
| L9400 | PPI抑制剂库 | 260 compounds | |
| A unique collection of 260 PPI-related compounds for drug screening; | |||
| CL0138 | Carbonic Anhydrase inhibitor kit | ||
| L4000 | 经典已知活性库 | 12862 compounds | |
| TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 12862 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other research. | |||
| L3500 | 组蛋白修饰化合物库 | 362 compounds | |
| A unique collection of 362 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| CL0096 | Wnt/β-catenin/PORCN inhibitor/activator kit | ||
| L9610 | 环肽库 | 58 compounds | |
| 58 species of cyclic peptide molecules for high-throughput and high-content screening; | |||
| DC1180 | 特权片段注释化合物库-Lyases | ||
| L9210 | 儿童药物库 | 1015 compounds | |
| A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening. | |||
| L9420 | 外泌体相关化合物库 | 54 compounds | |
| 54 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
| CL0106 | HIF/HIF-PH inhibitor/activator kit | ||
| NY1000 | 天然产物衍生物库 | 4000 compounds | |
| The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold). | |||
| L1800 | 抗感染化合物库 | 2977 compounds | |
| A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
| CL0130 | DUB inhibitor kit | ||
| L2151 | 化疗药物库 | 51 compounds | |
| 51 Chemotherapeutic drugs that can be used for high-throughput and high-content screening. | |||
| L7110 | 抗高血压化合物库 | 719 compounds | |
| 719 hypertension-related small molecules for high-throughput and high-content screening. | |||
| L2120 | 抗癌临床化合物库 | 2359 compounds | |
| A unique collection of 2359 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L7300 | 钾通道分子库 | 160 compounds | |
| A unique collection of 160 potassium channel blockers and agonists for high throughput and high content screening; | |||
| CL0137 | E1/E2/E3 Enzyme inhibitor kit | ||
| L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
| 369 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library | |||
| L2000 | 抑制剂库 | 7618 compounds | |
| A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L7500 | 凝血与抗凝化合物库 | 154 compounds | |
| A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| CL0069 | JAK inhibitor kit | ||
| CL0124 | AMPAR antagonist/activator kit | ||
| CL0119 | Histone Demethylase inhibitor kit | ||
| VM1400 | 多样性核心库Part2 | ||
| L6500 | 微生物天然产物库 | 254 compounds | |
| 254种微生物来源的生物活性小分子化合物的特有集合，用于高通量、高内涵筛选； | |||
| L8000 | 干细胞分化化合物库 | 1213 compounds | |
| A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | |||
| CL0135 | ROCK inhibitor kit | ||
| DC1050 | 特权片段注释化合物库-Voltage-gated | ||
| L6160 | Ro5类药天然产物库 | 2743 compounds | |
| A unique collection of 2743 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening; | |||
| L2100 | 抗癌化合物库 | 6854 compounds | |
| A unique collection of 6854 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L6810 | 中药单体化合物库 | 2688 compounds | |
| A unique collection of 2688 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism； | |||
| CL0089 | c-Met/HGFR inhibitor kit | ||
| DC1010 | 特权片段注释化合物库-GPCR Family A | ||
| L2510 | 脂代谢化合物库 | 496 compounds | |
| A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
| CL0075 | c-Kit inhibitor kit | ||
| L5510 | 肝脏毒性化合物库 | 1040 compounds | |
| A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening； | |||
| L4600 | 植物来源化合物库 | 3076 compounds | |
| A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
| CL0048 | Anti-HIV compound kit | ||
| L6130 | 萜类天然产物库 | 349 compounds | |
| A unique collection of 349 natural terpenes and terpenoids can be used for high throughput and high content screening； | |||
| CL0067 | Sodium Channel inhibitor kit | ||
| CL0059 | Dopamine Receptor inhibitor kit | ||
| CL0114 | ERK inhibitor kit | ||
| L3510 | 甲基化化合物库 | 131 compounds | |
| 131 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
| L2530 | 小鼠代谢化合物库 | 224 compounds | |
| A unique collection of 224 mouse metabolites, which can be used for HTS and HCS; | |||
| L6030 | 天然产物衍生物虚筛化合物库 | ||
| L7850 | 高溶解性3D结构多样性片段化合物库 | 1081 compounds | |
| The library of highly soluble 3D structural diversity fragments contains 1081 compounds. | |||
| DC1060 | 特权片段注释化合物库-Kinases | ||
| CL0118 | p38 inhibitor kit | ||
| L6220 | 蒙药化合物库 | 960 compounds | |
| A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
| CL0072 | BET inhibitor kit | ||
| CL0132 | DHFR inhibitor kit | ||
| CL0080 | TGFβ signaling pathway inhibitor/activator kit | ||
| L7840 | 高溶解性卤化片段化合物库 | 796 compounds | |
| The highly soluble halogenated fragment library contains 796 halogenated fragment compounds. | |||
| CL0139 | ROS inhibitor kit | ||
| CL0074 | Microtubule/Tubulin inhibitor kit | ||
| CL0068 | VEGFR inhibitor kit | ||
| CL0070 | GABA Receptor inhibitor kit | ||
| L7700 | 神经再生化合物库 | 529 compounds | |
| A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | |||
| CL0121 | ALK inhibitor kit | ||
| DC1220 | 特权片段注释化合物库-Aminoacyltransferases | ||
| CL0100 | Raf inhibitor kit | ||
| L2610 | 神经递质受体化合物库 | 1513 compounds | |
| A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening； | |||
| L2600 | 神经信号分子库 | 2011 compounds | |
| A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| CL0122 | ACE inhibitor kit | ||
| L9820 | β-内酰胺类化合物库 | 105 compounds | |
| A unique collection of 105 beta-lactam compounds, can be used in HTS and HCS; | |||
| DC1000 | 特权片段注释化合物库 | ||
| L7830 | 高溶解性片段药效团化合物库 | 985 compounds | |
| High Solubility Pharmacophore Fragment library contains 985 fragment small molecules. | |||
| CL0143 | PKA/cAMP inhibitor/activator kit | ||
| L2900 | 氧化还原化合物库 | 1279 compounds | |
| 1279 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | |||
| L9100 | 磷酸酶抑制剂化合物库 | 80 compounds | |
| A collection of 80 phosphatase inhibitors with known activity; | |||
| CL0126 | Androgen Receptor antagonist kit | ||
| Cat. No. | Product Name | ||
|---|---|---|---|
| EC2000 | 全自动封板仪 | ||
| EC1000 | 半自动移液工作站 | ||
| Cat. No. | Product Name | ||
|---|---|---|---|
| EC3000 | TargetMol® 24 道磁力架 | ||
| EC3001 | TargetMol® 16 道磁力架 | ||
| EC4000 | TargetMol® 高通量开盖器 | ||
| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| T22574L | Angiotensin 1/2 (5-7) acetate | RAAS | Endocrinology/Hormones |
| Angiotensin 1/2 (5-7) acetate is a peptide with the sequence H2N-Ile-His-Pro-OH. Angiotensin is an oligopeptide and is a hormone and a powerful dipsogen. It is derived from the precursor molecule angiotensinogen, a serum globulin produced in the liver. It | |||
| T8649 | TMBIM6 antagonist-1 | mTOR | PI3K/Akt/mTOR signaling |
| BIA is a bax inhibitor | |||
| TN5263 | 1-[2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one | NMDAR; PARP; HCV Protease; Caspase; Apoptosis; HIV Protease; IAP; p53; BCL | Neuroscience; Chromatin/Epigenetic; Apoptosis; Microbiology/Virology; DNA Damage/DNA Repair; Proteases/Proteasome |
| Xanthohumol, prenylchacone flavonoid, is a natural product with multi-biofunctions purified from Hops Humulus lupulus. Xanthohumol is effective against HIV-1 and might serve as an interesting lead compound. It may represent a novel chemotherapeutic agent | |||
| T9432 | 6-Bromo-2-naphthol | Others | Others |
| 6-Bromo-2-naphthol is an electrophilic carbene intermediate. | |||
| T38465 | 2,2-Dihydroxy-1-phenylethan-1-one | Antioxidant | oxidation-reduction |
| 2,2-Dihydroxy-1-phenylethan-1-one has antioxidant activity. | |||
| T9206 | 1-(2-Pyridylazo)-2-naphthol | Others | Others |
| 1-(2-Pyridylazo)-2-naphthol is a complexation index agent. | |||
| T9898 | 2-(7-Methoxy-1-naphthyl)ethylamine hydrochloride | Others | Others |
| 2-(7-Methoxy-1-naphthyl)ethylamine hydrochloride is the impurity of Agomelatine, an antidepressant. | |||
| T2769 | 3-Aminopropionitrile fumarate (2:1) | Others | Others |
| 3-Aminopropionitrile fumarate is an organic compound and antirheumatic agent used in veterinary medicine. | |||
| T9229 | Pim-1/2 kinase inhibitor 1 | Pim | Chromatin/Epigenetic; JAK/STAT signaling |
| Pim-1/2 kinase inhibitor 1 is an orally active pim-1/2 kinase inhibitor. Pim-1/2 kinase inhibitor 1 blocks the ability of Pim kinases to phosphorylate peptides, and inhibits the pim protein kinase directed phosphorylation of 4E-BP1 and p27 Kip1. Pim-1/2 kinase inhibitor 1 can be used in the cancer research, especially prostate cancer [1]. | |||
| T7339 | Angiotensin (1-7) | RAAS; Endogenous Metabolite | Endocrinology/Hormones; Metabolism |
| Angiotensin 1-7, also known as Ang-(1-7), is a synthetic heptapeptide identical to endogenous angiotensin-(1-7) , inhibits purified canine ACE activity (IC50=0.65 μM) with vasodilator and antiproliferative activities. | |||
| T50050 | 2,3-dihydroxy-3-methylbutanoic acid | Others | Others |
| 2,3-dihydroxy-3-methylbutanoic acid is a chemical compound. | |||
| T7663L | Angiotensin 1/2 (1-9) TFA(34273-12-6(free base)) | Others | Others |
| Angiotensin 1/2 (1-9)TFA is containing the amino acids 1-9 that are converted from Angiotensin I/II peptide. | |||
| T10735 | CDK4/6/1 Inhibitor | CDK | Cell Cycle/Checkpoint |
| CDK4/6/1 Inhibitor是一种 CDK4/6 抑制剂 (IC50s: 3 and 1 nM). CDK4/6抑制剂是一类用于治疗一些类型的激素受体阳性、her2阴性乳腺癌的化合物，可阻断了乳腺癌细胞分裂和繁殖的过程。 | |||
| T40728 | 1-Bromo-6-chlorohexane | ||
| 1-Bromo-6-chlorohexane is used as PROTAC linker. | |||
| T67751 | 1H-Indole-3-carboxylic acid, 5-[2-hydroxy-3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]propoxy]-2-methyl-1-(4-methylphenyl)-, ethyl ester | Beta Amyloid | Neuroscience |
| Compound 5936-0108 may has modulationg effect on β-Amyloid (patent WO 2007/134449). | |||
| T7483 | 6-Bromo-2-hydroxy-3-methoxybenzaldehyde | IRE1 | Cell Cycle/Checkpoint |
| 6-Bromo-2-hydroxy-3-methoxybenzaldehyde is an inhibitor of IRE-1α (IC50 : 0.08 μM). | |||
| T10033 | COX-2-IN-1 | COX | Immunology/Inflammation; Neuroscience |
| COX-2-IN-1 is a potent and selective COX-2 inhibitor (IC50: 3.9 μM). | |||
| T21355 | 6-Chloro-1-tetralone | Others | Others |
| 6-Chloro-1-tetralone is an important intermediate used for chemical synthesis. | |||
| T4873 | 2-Amino-1-phenylethanol | Endogenous Metabolite | Metabolism |
| 2-Hydroxyphenethylamine has been found in human testicle tissue, and has also been primarily detected in blood. 2-Hydroxyphenethylamine can be converted into 2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol. | |||
| TN6719 | Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside | Others | Others |
| Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside is a natural peoduct isolated from Arabian jasmine | |||
| TN7198 | 6-Bromoindole-3-acetonitrile | Others | Others |
| 6-Bromoindole-3-acetonitrile is a marine derived natural products found in Pseudosuberites hyalinus. | |||
| T19085 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC | Others | Others |
| 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC is a major component of biological membranes. It is used for the preparation of liposomes and studying the properties of lipid bilayers. | |||
| T21708L | Angiotensin 1/2 + A (2 - 8) Acetate | Others | Others |
| Angiotensin 1/2 + A (2 - 8) Acetate is a Vasoconstrictor. | |||
| T50090 | 3-(2-phenylethynyl)pyridine | Others | Others |
| 3-(2-phenylethynyl)pyridine is a chemical compound. | |||
| T4789 | 1-Hydroxy-2-naphthoic acid | Others; Endogenous Metabolite | Metabolism; Others |
| Metabolite from phenanthrene degradation. | |||
| T1696 | 2-(1-Piperazinyl)pyrimidine | Adrenergic Receptor | Neuroscience; GPCR/G Protein |
| 2-(1-Piperazinyl)pyrimidine is used as an anti-anxiety drug. | |||
| T9344 | 3-Amino-2-oxazolidinone | Others; Endogenous Metabolite | Others; Metabolism |
| 3-Amino-2-oxazolidinone (AOZ) is the metabolite of Furazolidone (HY-B1336). It is always be detected as a indicator of furazolidone residues in vivo. | |||
| TN7177 | 6-Bromoindole-3-carboxylic acid | Others | Others |
| 6-Bromoindole-3-carboxylic acid是一种海洋来源的天然产物，存在于Pseudosuberites hyalinus。 | |||
| T0663 | 2-Bromo-6-methoxynaphthalene | 5-HT Receptor | Neuroscience; GPCR/G Protein |
| 2-Bromo-6-methoxynaphthalene was used in the synthesis of nabumetone [4-(6-methoxy-2-naphthalenyl)-2-butanone] by Heck reaction. | |||
| T10736 | CDK4/6-IN-2 | CDK | Cell Cycle/Checkpoint |
| CDK4/6-IN-2 is a potent CDK4 and CDK6 inhibitor (IC50s: 2.7 and 16 nM) extracted from patent US20180000819A1 (Compound 1). | |||
| TN7132 | 4,12-Dimethoxy-6-(7,8-dihydroxy-7,8-dihydrostyryl)-2-pyrone | Others | Others |
| 4,12-Dimethoxy-6-(7,8-dihydroxy-7,8-dihydrostyryl)-2-pyrone is a microbial metabolism of yangonin, a major styryl lactone from Piper methysticum. | |||
| T6981 | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | Others | Others |
| Nudifloric Acid 是来源于冬虫夏草，能够靶向阻断AP-1 介导的荧光素酶活性，具有抗炎活性。其中冬虫夏草具有抗氧化，抗癌，抗炎，抗糖尿病，抗肥胖，抗血管生成和抗伤害感受活动。 | |||
| T9999 | Benzamide, N-(3-imidazo[2,1-b]thiazol-6-ylphenyl)-2-methoxy | Sirtuin; Others | Others; DNA Damage/DNA Repair; Chromatin/Epigenetic |
| Benzamide, N-(3-imidazo[2,1-b]thiazol-6-ylphenyl)-2-methoxy exhibits antidiabetic, anti-inflammatory and antitumor activities. | |||
| T37753 | Aureusimine B | Antibacterial; Cysteine Protease | Proteases/Proteasome; Microbiology/Virology |
| Aureusimine B, also known as phevalin, is a natural pyrazinone produced by certain fungi and by Staphylococcus spp., including S. aureus. Its synthesis appears to be initiated by a conserved nonribosomal peptide synthetase that creates a dipeptide (phenylalanine-valine) aldehyde, which then undergoes cyclization and oxidation. Aureusimine B inhibits calpain in a casein hydrolysis assay (IC50 = 1.3 μM), contributes to S. aureus infection in mice, and alters human keratinocyte gene expression. | |||
| T5105 | 1-(2-Pyridyl)piperazine | Adrenergic Receptor | Neuroscience; GPCR/G Protein |
| 1-(2-Pyridyl)piperazine is a selective α2-adrenoceptor antagonists. 1-(2-Pyridyl)piperazine shows sympatholytic activity. 1-(2-Pyridyl)piperazine is also a metabolite of Azaperone. | |||
| T23076L | Nociceptin (1-7) acetate | Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
| Nociceptin (1-7) acetate is a potent agonist of opioid receptor-like 1 (ORL1) receptor. Nociceptin (1-7) combines with nociceptin reduces hyperalgesia and has antinociceptive activity. | |||
| T13495 | 3-Amino-2-piperidinone | Endogenous Metabolite | Metabolism |
| 3-Amino-2-piperidinone is a metabolite from all living organisms and can be used as a cyclic ornithine analogue. | |||
| T2604 | 1-Ethyl-2-benzimidazolinone | Calcium Channel | Membrane transporter/Ion channel; Metabolism |
| 1-Ethyl-2-benzimidazolinone is a calium channel agonist. | |||
| T9854 | HIV-1 inhibitor-6 | HIV Protease | Proteases/Proteasome; Microbiology/Virology |
| 3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- is a potent HIV-1 pre-mRNA selective splicing inhibitor that blocks HIV replication. | |||
| T4371 | CD437 | Autophagy; Retinoid Receptor | Autophagy; Metabolism |
| CD437 is a specifc Retinoic Acid Receptor γ (RARγ) agonist. | |||
| T2S2173 | 2′,4,4′,6′-Tetrahydroxychalcone | Others | Others |
| 1. Naringenin chalcone has antiallergic activity 2. Naringenin chalcone suppresses asthmatic symptoms by inhibiting Th2 cytokine production from CD4 T cells. 3. Naringenin chalcone is a potent tomato flavonoid that improves adipocyte metabolic functions a | |||
| Fr12275 | 7-Methoxy-1-tetralone | Others | Others |
| 7-Methoxy-1-tetralone may have insecticidal activity. | |||
| T40709 | 3-Diethylamino-1-propanol | Others | Others |
| 3-Diethylamino-1-propanol exhibits anticonvulsant effects. | |||
| T4237 | Rubiadin-1-methyl ether | Anti-infection; NF-κB | Microbiology/Virology; NF-κB |
| Rubiadin 1-methyl ether is a natural product.It inhibits osteoclastic bone resorption via inhibition on the phosphorylation of NF-κB p65 and the degradation of IκBα as well as decrease in the nuclear translocation of p65. | |||
| T5232 | 3-Methyl-2-oxobutanoic acid | Others; Endogenous Metabolite | Metabolism; Others |
| alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. alpha-Ketoisovaleric acid is a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tis | |||
| T5901 | 3-Hydroxy-2-methylpyridine | Others | Others |
| 3-Hydroxy-2-methylpyridine could as a promising molecular scaffold for the future development of novel fibrillization inhibitors. | |||
| TN7202 | 3-Chloro-6-Bromo Indole | Others | Others |
| 3-Chloro-6-Bromo Indole is a marine derived natural products found in Ptychodera flava. | |||
| TN7021L | (+)-6-(2-Hydroxy-3-methoxy-3-methylbutyl | Others | Others |
| (+)-6-(2-Hydroxy-3-methoxy-3-methylbutyl is a chemical compound. | |||
| T4892 | 3-(2-Hydroxyphenyl)propanoic acid | Endogenous Metabolite | Metabolism |
| 3-(2-Hydroxyphenyl)propanoic acid, also known as melilotic acid or melilotate. Within the cell, 3-(2-hydroxyphenyl)propanoic acid is primarily located in the cytoplasm. 3-(2-Hydroxyphenyl)propanoic acid can be biosynthesized from propionic acid. Outside o | |||
| T4521 | Edg-2 receptor inhibitor 1 | LPA Receptor | GPCR/G Protein |
| Edg-2 receptor inhibitor 1 is an Edg-2 receptor inhibitor extracted (IC50: <0.1 μM). | |||
沪公网安备 31010602006700号
